Clinical evaluation of dried blood spots for the determination of ribociclib blood levels
Recruiting
- Conditions
- Advanced breast cancer
- Registration Number
- NL-OMON25336
- Lead Sponsor
- ovartis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1. Age = 18 years;
2. Able to understand the written information and able to give informed consent;
3. Treated with ribociclib;
4. Able and willing to undergo a finger prick for dried blood spot sampling.
Exclusion Criteria
1. Unable to draw blood for study purposes.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The main study parameter is the agreement between ribociclib plasma levels of blood collected by venipuncture or DBS.
- Secondary Outcome Measures
Name Time Method